Table 2

Risk of Parkinson’s disease in patients with IBD: a Danish nationwide cohort study 1977–2014

Patients with IBDNon-IBD individualsHR for individuals diagnosed with IBD compared with non-IBD individuals (reference)
EventsRate*EventsRate*Crude HR (95% CI)Adjusted† HR (95% CI)
IBD
 All3350.3739 7840.221.24 (1.12 to 1.38)1.22 (1.09 to 1.35)
Gender
 Female1480.2917 9500.191.27 (1.08 to 1.49)1.23 (1.05 to 1.45)
 Male1870.4621 8340.261.23 (1.06 to 1.41)1.20 (1.04 to 1.39)
Charlson Comorbidity Index
 0590.1389470.091 (reference)
 1–21340.4917 6130.391.83 (1.81 to 1.84)
 3–4940.8689940.662.04 (2.02 to 2.06)
 5–6380.6335410.501.68 (1.66 to 1.71)
 >7100.616890.511.59 (1.55 to 1.63)
Age at IBD diagnosis (years)
 <40240.0563740.041.32 (0.88 to 1.96)1.22 (0.82 to 1.82)
 40–651450.4922 2820.361.32 (1.12 to 1.56)1.25 (1.06 to 1.47)
 >651661.7311 1281.361.33 (1.14 to 1.54)1.30 (1.12 to 1.52)
Follow-up time (years)
 <14316.4111355.681.44 (1.07 to 1.94)1.36 (1.01 to 1.84)
 1–202300.4819 8910.311.24 (1.09 to 1.41)1.15 (1.01 to 1.31)
 >20620.1518 7580.101.37 (1.07 to 1.76)1.26 (0.98 to 1.62)
  • HRs are stratified by matching factors (gender and age).

  • *Incidence rate per 1000 person-years.

  • †HRs are adjusted for Charlson Comorbidity Index.